Aktienanalyse wird geladen …
UHS · NYSE · Hospitals · USA
176,99 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 17,36 Mrd. | 1,49 Mrd. | 23,10 $ | 64,46 Mio. | 0,5 Mio · 0,8 % | 4 Mio · 6,2 % | 90,5 % | 8,6 % | 13,17 $ | 1,48 $ | 0,80 $ |
| 2024 | 15,83 Mrd. | 1,14 Mrd. | 16,82 $ | 67,9 Mio. | 0,6 Mio · 0,8 % | 2,8 Mio · 4,1 % | 90 % | 7,2 % | 16,54 $ | 1,46 $ | 0,80 $ |
| 2023 | 14,28 Mrd. | 717,8 Mio. | 10,23 $ | 70,13 Mio. | 0,5 Mio · 0,7 % | 4,2 Mio · 6 % | 89,3 % | 5 % | 7,48 $ | 1,25 $ | 0,80 $ |
| 2022 | 13,4 Mrd. | 675,61 Mio. | 9,14 $ | 73,83 Mio. | 0,5 Mio · 0,7 % | 10,3 Mio · 14 % | 89 % | 5 % | 3,55 $ | 1,16 $ | 0,80 $ |
| 2021 | 12,64 Mrd. | 991,59 Mio. | 11,82 $ | 83,69 Mio. | 0,4 Mio · 0,5 % | 2,3 Mio · 2,8 % | 88,7 % | 7,8 % | 0,33 $ | 0,88 $ | 0,80 $ |
| 2020 | 11,56 Mrd. | 943,95 Mio. | 10,99 $ | 85,59 Mio. | 0,4 Mio · 0,4 % | 3,8 Mio · 4,5 % | 88,9 % | 8,2 % | 19,03 $ | 0,77 $ | 0,20 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,64 Mrd. | 358,45 Mio. | 5,98 $ | 59,91 Mio. | 7,7 % | 3,60 $ |
| Q1 2026 | 4,5 Mrd. | 348,68 Mio. | 5,65 $ | 61,67 Mio. | 7,8 % | 2,99 $ |
| Q4 2025 | 4,49 Mrd. | 445,94 Mio. | 6,92 $ | 63,16 Mio. | 9,9 % | 4,55 $ |
| Q3 2025 | 4,5 Mrd. | 372,96 Mio. | 5,86 $ | 63,66 Mio. | 8,3 % | 2,38 $ |
| Q2 2025 | 4,28 Mrd. | 353,22 Mio. | 5,43 $ | 64,99 Mio. | 8,3 % | 4,35 $ |
| Q1 2025 | 4,1 Mrd. | 316,68 Mio. | 4,80 $ | 66,04 Mio. | 7,7 % | 1,83 $ |
| Q4 2024 | 4,11 Mrd. | 332,4 Mio. | 5,16 $ | — | 8,1 % | 6,40 $ |
| Q3 2024 | 3,96 Mrd. | 258,71 Mio. | 3,80 $ | — | 6,5 % | — |
Universal Health Services Stock: Is UHS Underperforming the Health Care Sector?
Leerink Partners Adjusts Universal Health Services PT to $205 From $198, Maintains Outperform Rating
JPMorgan Adjusts Universal Health Services Price Target to $200 From $205, Maintains Neutral Rating
Why Is Universal Health Services (UHS) Up 5.7% Since Last Earnings Report?
Universal Health Services Inc. Class B Common Stock represents an equity interest in Universal Health Services, a healthcare services company that owns and operates acute care hospitals, behavioral health facilities, surgical hospitals, ambulatory surgery centers, and related outpatient care centers. Universal Health Services serves patients through a broad network of medical and behavioral health services, including emergency care, specialty medicine, diagnostic imaging, surgery, rehabilitation, psychiatric treatment, and addiction-focused programs. The company’s operations are organized around hospital-based and behavioral health segments, supported by centralized management and administrative services that help coordinate clinical delivery, purchasing, finance, and facility operations. Universal Health Services plays a significant role in the U.S. healthcare market by providing essential inpatient and outpatient services across multiple care settings and patient needs.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest UHS und jede andere Aktie unbegrenzt.